AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (September 8, 2006). doi:10.1152/ajpheart.00766.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/H259    most recent
00766.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boateng, S. Y.K
Right arrow Articles by Russell, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boateng, S. Y.K
Right arrow Articles by Russell, B.
Submitted on July 17, 2006
Accepted on September 3, 2006

Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein

Samuel Y.K Boateng1, Rashad J. Belin2, David L. Geenen3, Kenneth B Margulies4, Jody L Martin5, Masahiko Hoshijima6, Pieter P. de Tombe7, and Brenda Russell8*

1 Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois, United States
2 Physiology & Biophysics, University of Illinois at Chicago, Chicago, Illinois, United States; Preventive Medicine, Northwestern University, 680 N. Lake Shore Dr., CHicago, Illinois, 60611, United States
3 Cardiology Secton, M/C 787, University of Illinois at Chicago, Chicago, Illinois, United States
4 Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, Pennsylvania, United States
5 Cardiovascular Institute, Loyola University, Maywood, Illinois, United States
6 Medicine, UCSD, La Jolla, California, United States
7 Dept. of Physiology & Biophysics, Univ. of Illinois at Chicago, Chicago, Illinois, United States
8 Department of Physiology and Biophysics, UIC, Chicago, Illinois, United States

* To whom correspondence should be addressed. E-mail: russell{at}uic.edu.

Prolonged hemodynamic overload results in cardiac hypertrophy and failure with detrimental changes in myocardial gene expression and morphology. CSRP3 or muscle LIM protein (MLP) is thought to be a mechanosensor in cardiac myocytes. Therefore, the subcellular location of MLP may have functional implications in health and disease. Our hypothesis is that MLP becomes mislocalized after prolonged overload resulting in impaired mechanosensing in cardiac myocytes. Using the techniques of biochemical subcellular fractionation and immunocytochemistry, we found MLP exhibits oligomerization in the membrane and cytoskeleton of cultured cardiac rat neonatal myocytes. Nuclear MLP was always monomeric. MLP translocated to the nucleolus in response to 10% cyclic stretch at 1Hz for 48 hours. This was associated with a 3 fold increase in S6 ribosomal protein (p<0.01 n=3 cultures). Adenoviral over-expression of MLP also resulted in a 2 fold increase in S6 protein suggesting that MLP can activate ribosomal protein synthesis in the nucleolus. In ventricles from aortic banded and myocardial infarcted rat hearts, nuclear MLP increased by 2 fold (p<0.01 n=7) along with a significant decrease in the non-nuclear oligomeric fraction. The ratio of nuclear to non-nuclear MLP increased 3 fold in both groups (p<0.01 n=7). In failing human hearts there was almost a complete loss of oligomeric MLP. Using a flag-tagged adenoviral MLP, we demonstrate that the C-terminus is required for oligomerization and that this is a precursor to stretch sensing and subsequent nuclear translocation. Therefore, reduced oligomeric MLP in the costamere and cytoskeleton may contribute to impaired mechanosensing in heart failure.




This article has been cited by other articles:


Home page
Circ. Res.Home page
A. M. Samarel
PICOT: A Multidomain Scaffolding Inhibitor of Hypertrophic Signal Transduction
Circ. Res., March 28, 2008; 102(6): 625 - 627.
[Full Text] [PDF]


Home page
Circ. Res.Home page
D. Jeong, J. M. Kim, H. Cha, J. G. Oh, J. Park, S.-H. Yun, E.-S. Ju, E.-S. Jeon, R. J. Hajjar, and W. J. Park
PICOT Attenuates Cardiac Hypertrophy by Disrupting Calcineurin-NFAT Signaling
Circ. Res., March 28, 2008; 102(6): 711 - 719.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.